Loading...
Loading...
CMPS| Name | Value |
|---|---|
| Revenues | 3.7M |
| Cost of Revenue | 1.8M |
| Gross Profit | 1.8M |
| Operating Expense | 38.7M |
| Operating I/L | -38.7M |
| Other Income/Expense | 6.3M |
| Interest Income | 0.0M |
| Pretax | -35.8M |
| Income Tax Expense | -3.0M |
| Net Income/Loss | -32.8M |
COMPASS Pathways plc is a mental health care company operating in the UK and the US. It focuses on developing COMP360, a psilocybin therapy for treatment-resistant depression and post-traumatic stress disorder. The company generates revenue through the development and potential commercialization of its innovative mental health treatments.
